Alpha-GPC and Physical and Cognitive Performances in Volleyball Players. (VolleyAGPC)
Effects of Alpha-glycerylphosphorylcholine on Physical and Cognitive Performances in Varsity Volleyball Players
Sponsor: Université de Montréal
A NA clinical study on Athletic Performance, this trial is completed. The trial is conducted by Université de Montréal and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
May 2017 — Jun 2018 [monthly]
Completed NA
Status: Recruiting → Completed · Phase: PHASE2 → NA
▶ Show 1 earlier version
-
Jan 2017 — May 2017 [monthly]
Recruiting PHASE2
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Université de Montréal
For direct contact, visit the study record on ClinicalTrials.gov .